Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non-Current Assets (2024 - 2025)

Historic Other Non-Current Assets for Madrigal Pharmaceuticals (MDGL) over the last 9 years, with Q3 2025 value amounting to $5.0 million.

  • Madrigal Pharmaceuticals' Other Non-Current Assets changed 0.0% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Other Non-Current Assets stood at $5.0 million for Q3 2025, which was down 0.0% from $5.0 million recorded in Q2 2025.
  • Madrigal Pharmaceuticals' 5-year Other Non-Current Assets high stood at $5.0 million for Q2 2024, and its period low was $5.0 million during Q2 2024.